After 11 years of development and barely one full year of sales, New York–based Pfizer dumped the much-anticipated inhaled powder insulin product Exubera on 18 October. This was particularly bad ...
The interest in inhalation delivery has continued to rise and was not hindered by the withdrawal of the first inhaled insulin, Exubera, in 2007. In fact over the past four years, 1,350 active ...
Story continues below this ad An inhaled form of insulin (Exubera) was available for a short time (2006-2007) but failed to gain acceptance by patients and clinicians. This was largely due to the ...
Rádio Montes Claros 98FM Anuncie na 98FM Ouça a 98FM Conheça a 98FM Peça sua música Fale com a Rádio Seja repórter da 98FM Rádio Jovem Pan 93,5FM Anuncie na 93,5FM Ouça a 93,5FM Peça sua música Fale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback